INVO Fertility shares surge 13.56% premarket after signing definitive agreement to acquire Family Beginnings fertility clinic.

INVO Fertility (IVF) rose 13.56% in premarket trading after announcing a definitive $750,000 agreement to acquire Indiana-based fertility clinic Family Beginnings, marking a critical step in its expansion strategy. The transaction includes $350,000 in cash (subject to a $150,000 holdback) and $400,000 in Series D preferred stock, with the acquisition expected to close by February 27, 2026. Family Beginnings reported $1.2 million in trailing 12-month revenue and $0.2 million in net income, aligning with INVO’s goal to enhance access to cost-effective fertility care. CEO Steve Shum highlighted the clinic’s clinical reputation and complementary services, including IVF and IVC procedures using INVO’s proprietary INVOcell device. The deal expands INVO’s U.S. footprint and reinforces its focus on integrating profitable fertility centers, driving investor optimism about growth prospects.